Q3 2022

Source filing unavailable

Q3 2022 · —

Revenue—

Net Income

-$42.77M

no prior Q3 2021 on file

EPS Diluted

-$0.47

no prior Q3 2021 on file

Operating Income-$37,347,000—

Same quarter

Metric	Q3 2022	Q3 2020	Q3 2019	Q3 2018
Revenue	—	—	$297.00K	$307.00K
Net Income	-$42.77M	-$37.32M	-$27.25M	-$12.86M
EPS Diluted	-$0.47	-$0.72	-$0.61	-$0.33

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Autolus Therapeutics plc · CIK 1730463 · Engraved from SEC EDGAR